JY
RXST icon

Jeff Yass’s RxSight RXST Stock Holding History

Jeff Yass’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-54,900
Closed -$1.39M – 13585
2025
Q1 		$1.39M Sell
54,900
-183,100
-77% -$5.44M ﹤0.01% 6413
2024
Q4 		$8.18M Buy
238,000
+39,300
+20% +$1.77M ﹤0.01% 2903
2024
Q3 		$9.82M Buy
198,700
+176,000
+775% +$9.02M ﹤0.01% 2636
2024
Q2 		$1.37M Buy
22,700
+11,900
+110% +$680K ﹤0.01% 5867
2024
Q1 		$557K Sell
10,800
-1,800
-14% -$88.4K ﹤0.01% 8262
2023
Q4 		$508K Sell
12,600
-108,700
-90% -$3.19M ﹤0.01% 8628
2023
Q3 		$3.38M Buy
+121,300
New +$3.62M ﹤0.01% 4180

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jeff Yass's RXST Position: Q2 2026 in Review

Jeff Yass reduced its RxSight (RXST) stake by 57% in Q2 2026, selling an estimated $242K and leaving 30,238 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #12228.

Jeff Yass first reported a position in RXST in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.57M in Q2 2023. 150 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Jeff Yass held 30,238 shares of RxSight worth $146K as of Q2 2026.
  • Jeff Yass sold 40,055 RxSight shares in Q2 2026, an estimated $242K.
  • RxSight made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12228 holding.
  • Jeff Yass first reported a position in RxSight in Q1 2022 and has held it in 15 quarters since.
  • Jeff Yass's RxSight position peaked at $1.57M in Q2 2023.
  • 150 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.